Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

The Role of Platelet Rich Plasma for Erectile Dysfunction

ID
Name
0156-20-FB
Description
Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.
Trial arms
Trial start
2021-04-01
Estimated PCD
2022-11-02
Trial end
2022-11-02
Status
Terminated
Phase
Early phase I
Treatment
Platelet rich plasma
PRP will be used in the experimental arm.
Arms:
Platelet rich plasma
Other names:
blood plasma
Placebo Sham Injection
sham injection
Arms:
Placebo
Other names:
Placebo
Size
13
Primary endpoint
Erectile Function Change
at 1, 3 and 6 months
Eligibility criteria
Inclusion Criteria: * history of mild to moderate erectile dysfunction measured by IIEF Exclusion Criteria: * history or prostate cancer treatment (prostatectomy, radiation, brachytherapy)
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Randomized Controlled Trial', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 13, 'type': 'ACTUAL'}}
Updated at
2023-08-29

1 organization

1 product

1 indication

Organization
University of Nebraska
Product
Platelet rich plasma
Indication
Impotence